← Back to Search

Unknown

GLS-1027 for COVID-19

Phase 2
Waitlist Available
Research Sponsored by GeneOne Life Science, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

This trialtests a drug to prevent lung damage from severe cases of COVID-19.

Who is the study for?
This trial is for adults over 18 who can consent and follow study procedures, have a confirmed SARS-CoV-2 diagnosis, and are hospitalized but not on high-flow oxygen or mechanical ventilation. Pregnant individuals, those with severe kidney issues, recent chemotherapy patients, organ transplant recipients, or those in other COVID-19 drug trials cannot join.
What is being tested?
The trial is testing GLS-1027's ability to prevent severe lung inflammation (pneumonitis) caused by COVID-19 compared to a placebo. Participants will be randomly assigned to receive either the experimental drug GLS-1027 or an inactive substance with no therapeutic effect.
What are the potential side effects?
While specific side effects of GLS-1027 aren't listed here, common side effects may include allergic reactions, gastrointestinal symptoms like nausea or diarrhea, headaches, fatigue and potential liver enzyme abnormalities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: GLS-1027 360 mgExperimental Treatment1 Intervention
Three 120 mg pills of GLS-1027 given by mouth once daily
Group II: GLS-1027 120 mgExperimental Treatment1 Intervention
One 120 mg pill of GLS-1027 + 2 Placebo pills given by mouth once daily
Group III: PlaceboPlacebo Group1 Intervention
Three Placebo pills given by mouth once daily

Find a Location

Who is running the clinical trial?

GeneOne Life Science, Inc.Lead Sponsor
15 Previous Clinical Trials
1,308 Total Patients Enrolled
~29 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top